Date: September 16th, 2026
Location: Noto’s Old World Italian Dining | 6600 28th St SE, Grand Rapids, MI 49546
Time: Registration begins at 6:30 PM | Dinner & presentation begin at 7:00 PM
Topic: Managing Hypertrophic Cardiomyopathy in Feline Patients
PROGRAM OVERVIEW
Introducing the first FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM).
This first-in-class drug is now available to manage progressive left ventricular (LV) hypertrophy in cats with subclinical HCM. Now you have a reason to screen to intervene and manage subclinical HCM in your feline patients. We will outline the pathophysiology of HCM and review the indications for Felycin-CA1.
Note:
- This event is limited to 40 attendees
- This event is RACE Approved
- This meeting is open to member veterinarians at this time.
Speaker:
Lillian Rogers, BVMS
Cat Friendly Veterinarian Certified
Feline Heart Health Certified